Investor Presentaiton

Transformation over Last 5 Years - Diversified underlying business growth [Crores] 24 24 2,056 742 744 + 24% CAGR 402 1972 125 6,041 FY 18 ARV ΑΡΙ (Onco+Others) FDF (ex-ARV) CDMO BIO^ FY 23 ^ Reflects revenues since Feb 2021, when we acquired Laurus Bio Laurus Q2 & H1 FY 2024 Investor Presentation | October 20, 2023 Diversification of Laurus business FY 18 2,056 Cr ARV 73% FY 23 * 6,041 Cr 37% 36% 7% 18% ■ ARV ■API (Onco+Others) ■FDF (ex-ARV) ■ CDMO ■ Bio LAURUS Labs Knowledge. Innovation. Excellence

View entire presentation